1832 Asset Management L.P. Astrazeneca PLC Transaction History
1832 Asset Management L.P.
- $48.7 Billion
- Q1 2025
A detailed history of 1832 Asset Management L.P. transactions in Astrazeneca PLC stock. As of the latest transaction made, 1832 Asset Management L.P. holds 10,726 shares of AZN stock, worth $791,900. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,726
Previous 25,696
58.26%
Holding current value
$791,900
Previous $1.68 Million
53.18%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding AZN
# of Institutions
1,428Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.21 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$3 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.63 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.35 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.31 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $229B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...